论文部分内容阅读
目的 :探讨小儿肺炎通过热毒宁注射液治疗30例的效果,为热毒宁注射液治疗小儿肺炎的临床应用提供理论依据。方法:选取2014年5月-2016年5月在医院接受治疗的60例肺炎患儿作为此次研究对象,并将其随机分为观察组与对照组,每组患儿30例,给予对照组患儿抗生素进行治疗,观察组患儿在对照组的基础上联合热毒宁注射液进行治疗,观察两组患儿的临床症状变化情况,分析比较两组患儿体征改善时间情况、临床疗效情况、并发症发生情况。结果 :观察组患儿体征改善时间相比于对照组患儿明显缩短,组间比较具有统计学意义(P<0.05);观察组患儿总有效率为96.67%,对照组为76.67%,组间比较具有统计学意义(P<0.05);观察组患儿并发症发生率为6.67%,对照组为20%,组间比较具有统计学意义(P<0.05)。结论 :小儿肺炎通过热毒宁注射液治疗30例的效果显著,改善了临床症状和生活质量,缩短了治疗时间,降低了并发症的产生,提高了治愈率,临床上值得推广应用。
Objective: To investigate the effect of pediatric pneumonia treated with Reverining Injection in 30 patients and to provide a theoretical basis for the clinical application of Reboxen injection in treating children with pneumonia. Methods: Sixty children with pneumonia who were treated in the hospital from May 2014 to May 2016 were selected as the study subjects and randomly divided into observation group and control group, 30 cases in each group were given control group Children with antibiotics were treated. The observation group was treated with Renduining injection on the basis of the control group, and the changes of clinical symptoms in both groups were observed. The signs and symptoms of the two groups were compared and the clinical curative effect Complications occurred. Results: The improvement time of children in observation group was significantly shorter than that in control group (P <0.05). The total effective rate was 96.67% in observation group and 76.67% in control group (P <0.05). The incidence of complication in the observation group was 6.67% and in the control group was 20%, the difference between the two groups was statistically significant (P <0.05). Conclusion: The treatment effect of 30 children with pneumonia through Revinu injection is remarkable, which improves the clinical symptoms and quality of life, shortens the treatment time, reduces the complications and improves the cure rate. It is worth popularizing and applying clinically.